MASLD associated with increased risk of bacterial infections: Study
A new study published in the journal of Liver International unveiled a strong correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) and a higher risk of severe bacterial infections that need hospitalization. An increasing amount of epidemiological data indicates that MASLD may be associated with liver-related problems as well as extrahepatic malignancies, newly developed type 2 diabetes, cardiovascular events, and poor renal outcomes. The primary cause of liver-related morbidity and death as well as the most frequent cause of chronic liver disease is MASLD.
Prior research has indicated a correlation between the risk of severe bacterial infections and steatotic liver disease linked to metabolic dysfunction. It is unclear, therefore, how big the risk is and if it changes depending on how severe MASLD is. Alessandro Mantovani and colleagues assessed the correlation between MASLD and severe bacterial infections necessitating hospitalization by conducting a meta-analysis of observational data.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.